Fate Therapeutics Inc. Stock
We can see a decrease in the price for Fate Therapeutics Inc.. Compared to yesterday it has lost -€0.560 (-1.090%).
Currently there is a rather positive sentiment for Fate Therapeutics Inc. with 5 Buy predictions and 0 Sell predictions.
As a result the target price of €86.00 shows a very positive potential of 69.692% compared to the current price of €50.68 for Fate Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the Fate Therapeutics Inc. stock. Criterium "Investment quota" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Fate Therapeutics Inc. in the next few years
Pros
1
Standard Investments for future growth
1
Innovative
1
Some uniques
Cons
2
Probably not worthwhile Investment
Performance of Fate Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Fate Therapeutics Inc. | -1.090% | -3.979% | -14.014% | 25.446% | -33.316% | - | - |
| Clovis Oncology Inc. | -2.230% | -0.560% | -1.582% | -19.465% | 2.387% | -79.381% | -88.027% |
| Biocryst Pharmaceuticals | -0.480% | -3.218% | -4.137% | 289.214% | 123.145% | 125.536% | 202.660% |
| Champions Oncology Inc | -0.580% | -0.578% | -4.972% | 13.158% | -4.972% | - | - |
Comments
Other discussions about Fate Therapeutics Inc. Stock
Trading Fate Therapeutics Inc.
Trading Fate Therapeutics Inc.
